Mandatory Baxter Infusion Pump Recall Will Cost Up To $600 Million

Baxter will recall all of its Colleague infusion pumps on the U.S. market at an initial cost of up to $600 million, the firm disclosed May 3

More from Archive

More from Medtech Insight